New research is being presented at the American Diabetes Association’s 73rd Scientific Sessions from June 21-25 in Chicago.

“Quick, get the team doctor! And a vet, just to be safe!”

APA Leaders Defend DSM-5 | Alzheimer's Disease, Articles, Conference Coverage Releases, Depression, Psychiatry

SAN FRANCISCO -- The fifth edition of the "psychiatrist's bible" was officially released here in all its 947-page glory, with its developers offering a spirited rebuttal to their critics. Known as DSM-5, the new version of the American Psychiatric Association's (APA) Diagnostic and Statistical Ma ...

Continue Reading >

AAN 2013: Add-On Drug May Improve Memory in Moderate Alzheimer’s | Alzheimer's Disease, Articles, Conference Coverage Releases, Neurology

A new drug may improve memory problems in people with moderate Alzheimer’s disease, according to a phase IIa study released today that will be presented at the American Academy of Neurology’s 65th Annual Meeting in San Diego, March 16 to 23, 2013. The drug is called ORM-12741. The drug is the ...

Continue Reading >

Delirium Among Hospitalized AD Patients: The Long-Term Impact

Delirium Among Hospitalized AD Patients: The Long-Term Impact | Alzheimer's Disease, Articles, Emergency Medicine, Hospital Medicine, Neurology, Primary Care, Psychiatry, Recent Features, Slider

Little attention has been paid to the consequences of delirium on cognitive deterioration among patients with Alzheimer’s disease

Continue Reading >

 

 

 

Physician's Weekly for Current Medical News, Events & Issues